In vitro cytogenetic evaluation of the particular combination of flurbiprofen and roxithromycin


TIMOCIN T., HÜSUNET M. T. , Valipour E., TAZEHKAND M. N. , CELIK R., TOPAKTAŞ M. , et al.

DRUG AND CHEMICAL TOXICOLOGY, cilt.40, ss.326-332, 2017 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 40 Konu: 3
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1080/01480545.2016.1223097
  • Dergi Adı: DRUG AND CHEMICAL TOXICOLOGY
  • Sayfa Sayısı: ss.326-332

Özet

Flurbiprofen (FLB) (anti-inflammatory and analgesic drug) and roxithromycin (RXM) (antibiotic) were widely used in world wide. This study deals with investigation of genotoxicity, cytotoxicity, and oxidative stress effects of a particular combination of these drugs in human cultured lymphocytes. Also, DNA damaging-protective effects of combination of these drugs were analyzed on plasmid DNA. Human lymphocytes were treated with different concentrations (FLB+RXM; 10 mu g/mL+25 mu g/mL, 15 mu g/mL+50 mu g/mL, and 20 mu g/mL+100 mu g/mL) of the drugs following by study of their genotoxic and cytotoxic effects by analysis of cytokinesis-block micronucleus test and nuclear division index, respectively. The effect of the combination in aspect of anti-oxidative and DNA damaging activity was evaluated on Pet-22b plasmid. According to our results, the combination of FLB and RXM did not show a notable genotoxic effect on cells. Although each of the substances had been shown as a cytotoxic agent by previous researchers, in this research, the combination of these drugs did not exhibit any adverse effect on cell division. FLB had DNA protection effect against H2O2 while in combination with RXM had not the same effect on the plasmid.